TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN RUXOLITINIB-TREATED PATIENTS WITH MYELOFIBROSIS WITH AND WITHOUT ANEMIA: A REAL-WORLD ANALYSIS

被引：0
|
作者：
Liu, T. [1 ]
Fillbrunn, M. [2 ]
Chen, J. [2 ]
Sajeev, G. [2 ]
Zhang, S. [3 ]
Signorovitch, J. [2 ]
机构：
[1] GSK plc, Philadelphia, PA USA
[2] Anal Grp Inc, Boston, MA USA
[3] GSK, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [41] Ruxolitinib for myelofibrosis in elderly non-transplant patients: healthcare resource utilization and costs
    Gerds, Aaron T. T.
    Yu, Jingbo
    Shah, Anne
    Xi, Ann
    Kumar, Shambhavi
    Scherber, Robyn
    Parasuraman, Shreekant
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 843 - 849
  • [42] Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Waldenstrom Macroglobulinemia Initiating First-Line Treatment with Ibrutinib or Zanubrutinib
    Paludo, Jonas
    Sarosiek, Shayna R.
    von Keudell, Gottfried R.
    Salkar, Monika
    Zhou, Summera
    Kim, Sonia
    Cheng, Ning
    Pacia, Michelle
    Karve, Sudeep
    Castillo, Jorge J.
    BLOOD, 2023, 142
  • [43] Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib
    Passamonti, Francesco
    Parikh, Rohan C.
    Korgaonkar, Siddhi
    Chevli, Manoj
    Slaff, Samantha
    Rombi, Julien
    Adeyemi, Basirat
    Davis, Keith L.
    Yucel, Aylin
    BLOOD, 2023, 142
  • [44] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH METASTATIC BREAST CANCER: A RETROSPECTIVE COHORT ANALYSIS
    Hanson, K.
    Cha-Silva, A.
    Hull, M.
    DeKoven, M.
    Anupindi, V. R.
    Doshi, R.
    Rocque, G.
    VALUE IN HEALTH, 2023, 26 (06) : S110 - S110
  • [45] End-of-life healthcare resource utilization and costs in patients with PAH: a real-world analysis
    Weiss, Tracey
    Ramey, Dena Rosen
    Ngan Pham
    Shaikh, Nazneen
    Tian, Dajun
    Zhao, Xiaohui
    Near, Aimee
    Nathan, Steven
    Lautsch, Dominik
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [46] Real-World Treatment Patterns, Healthcare Cost and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US
    Chopra, D.
    Waterhouse, D. M.
    Sultan, I.
    Lonshteyn, A.
    Delea, T. E.
    Stollenwerk, B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S400 - S401
  • [47] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Tencer, T.
    Xia, Q.
    Jobson, G.
    Qian, E.
    Dellon, E. S.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [48] Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir-Ritonavir: Real-World Data Analysis
    Weil, Clara
    Tene, Lilac
    Chodick, Gabriel
    Fallach, Noga
    Ansari, Wajeeha
    Distelman-Menachem, Tal
    Maor, Yasmin
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [49] Treatment Patterns, Adherence, Persistence, and Health Care Resource Utilization in Acromegaly: A Real-World Analysis
    Fleseriu, Maria
    Barkan, Ariel
    Brue, Thierry
    Duquesne, Edouard
    Houchard, Aude
    Schneider, Maria del Pilar
    Ribeiro-Oliveira Jr, Antonio
    Melmed, Shlomo
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (10)
  • [50] Ruxolitinib Retreatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes
    Gerds, Aaron
    Yu, Jingbo
    Parasuraman, Shreekant
    Paranagama, Dilan
    Kish, Jonathan K.
    Visaria, Jay
    Singhal, Mukul
    Verstovsek, Srdan
    Pemmaraju, Naveen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S325 - S326
12345